Kura Oncology, Inc. announced the appointment of Steven H. Stein, M.D., to its board of directors. Dr. Stein currently serves as Executive Vice President and Chief Medical Officer of Incyte Corporation. Previously, Dr. Stein worked for Novartis Pharmaceuticals Corporation, where he most recently served as Senior Vice President, U.S. Clinical Development & Medical Affairs at Novartis Oncology U.S. Prior to Novartis, Dr. Stein worked at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care.